Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study

被引：0
|
作者：
Lombardi, D. [1 ]
Scalone, S. [1 ]
Crivellari, D. [1 ]
La Mura, N. [1 ]
Miolo, G. [1 ]
Murrone, A. [1 ]
Perin, T. [1 ]
Coran, F. [1 ]
Candiani, E. [1 ]
Massarut, S. [1 ]
Veronesi, A. [1 ]
机构：
[1] Ctr Riferimento Oncol, I-33081 Aviano, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [21] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    Espinosa, E
    Morales, S
    Borrega, P
    Casas, A
    Madroñal, C
    Machengs, I
    Illarramendi, J
    Lizón, J
    Moreno, J
    Belón, J
    Janáriz, J
    de la Puente, M
    Checa, T
    Mel, JR
    Barón, MG
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 546 - 552
  • [22] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [23] Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer
    Grazia, Artioli
    Simone, Mocellin
    Lucia, Borgato
    Alessandro, Cappetta
    Fernando, Bozza
    Giorgio, Zavagno
    Stefania, Zovato
    Alberto, Marchet
    Davide, Pastorelli
    [J]. ANTICANCER RESEARCH, 2010, 30 (09) : 3817 - 3821
  • [24] Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
    Al-Tweigeri, Taher A.
    Ajarim, Dahish S.
    Alsayed, Adher A.
    Rahal, Mohamed M.
    Alshabanah, Mohamed O.
    Tulbah, Asma M.
    Al-Malik, Osama A.
    Fatani, Doha M.
    El-Husseiny, Gamal A.
    Elkum, Naser B.
    Ezzat, Adnan A.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (03) : 571 - 577
  • [25] Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
    Taher A. Al-Tweigeri
    Dahish S. Ajarim
    Adher A. Alsayed
    Mohamed M. Rahal
    Mohamed O. Alshabanah
    Asma M. Tulbah
    Osama A. Al-Malik
    Doha M. Fatani
    Gamal A. El-Husseiny
    Naser B. Elkum
    Adnan A. Ezzat
    [J]. Medical Oncology, 2010, 27 : 571 - 577
  • [26] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    [J]. JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [27] Neoadjuvant sequential treatment with epirubicin plus docetaxel followed by capecitabine plus docetaxel in locally advanced breast cancer:: XELOGET:: a pilot study.
    Bourgeois, H.
    Soulie, P.
    Delva, R.
    Abadie-Lacourtoisei, S.
    Van Praagh, I
    Mouret-Reynier, M-A
    Lortholary, A.
    Chieze, S.
    Raban, N.
    Mac Grogan, G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S155 - S155
  • [28] Neoadjuvant Docetaxel in Locally Advanced Breast Cancer
    Andrew W. Hutcheon
    Steven D. Heys
    Tarun K. Sarkar
    [J]. Breast Cancer Research and Treatment, 2003, 79 (Suppl 1) : 19 - 24
  • [29] Neoadjuvant docetaxel in locally advanced breast cancer
    Hutcheon, AW
    Heys, SD
    Sarkar, TK
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 : S19 - S24
  • [30] Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study
    Mavroudis, D
    Alexopoulos, A
    Ziras, N
    Malamos, N
    Kouroussis, C
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Tsavaris, N
    Potamianou, A
    Rigatos, G
    Georgoulias, V
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (10) : 1249 - 1254
12345